NCT05954910 2026-02-02
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche
Active not recruiting
Hoffmann-La Roche
Jiangsu Cancer Institute & Hospital